N. Hedin

发表

Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy.

B. Wood, F. Appelbaum, J. Pagel, 2008, Blood.

Comparison of anti-CD 20 and anti-CD 45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas

J. Pagel, D. Wilbur, D. Meyer, 2003 .

Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas.

Damon L. Meyer, J. Pagel, D. Wilbur, 2003, Blood.

Comparative biodistributions of pretargeted radioimmunoconjugates targeting CD20, CD22, and DR molecules on human B-cell lymphomas.

J. Pagel, D. Hamlin, D. Wilbur, 2007, Blood.

Evaluation of CD20, CD22, and HLA-DR targeting for radioimmunotherapy of B-cell lymphomas.

J. Pagel, D. Hamlin, D. Wilbur, 2007, Cancer research.

anti-CD20 radioimmunotherapy of B-cell lymphomas protein and an antibody-streptavidin chemical conjugate for pretargeted Comparison of a tetravalent single-chain antibody-streptavidin fusion

J. Pagel, D. Wilbur, O. Press, 2013 .

Comparison of a tetravalent single-chain antibody-streptavidin fusion protein and an antibody-streptavidin chemical conjugate for pretargeted anti-CD20 radioimmunotherapy of B-cell lymphomas.

J. Pagel, D. Hamlin, D. Wilbur, 2006, Blood.

Pretargeted Radioimmunotherapy for B-Cell Lymphomas

J. Pagel, D. Hamlin, D. Wilbur, 2007, Clinical Cancer Research.

Fenretinide enhances rituximab-induced cytotoxicity against B-cell lymphoma xenografts through a caspase-dependent mechanism.

J. Pagel, O. Press, A. Gopal, 2004, Blood.

A genetically engineered anti-CD45 single-chain antibody-streptavidin fusion protein for pretargeted radioimmunotherapy of hematologic malignancies.

J. Pagel, O. Press, Yukang Lin, 2006, Cancer research.

Conventional and Pretargeted Radioimmunotherapy Using an Anti-Murine CD45 Monoclonal Antibody in a Syngeneic, Disseminated Murine Leukemia Model.

F. Appelbaum, J. Pagel, D. Hamlin, 2006 .